为科学家赋能 – BIOMEX 的新主张和新使命
让成功成为可能是我们对成功的定义我们的新口号 “EMPOWERING SCIENTISTS  Read More
BIOMEX收购Atreide
BIOMEX, Europe’s leading provider of human biospecimens and services for the diagnostics industry, announced today the acquisition of Atreide Biosamples in an asset deal.
BIOMEX支持儿童伯基特淋巴瘤的癌症研究
With a donation of 40,000 euros, BIOMEX supports the excellent work of two university research groups working on Burkitt’s lymphoma in children, a fast-growing cancer of the lymphatic system.
BIOMEX 的中国分公司内卡生物技术公司在上海开设新办事处
BIOMEX intensifies its China business with the opening of the Neckar Biotechnology branch and new offices in Shanghai.
支持乌克兰 +++ BIOMEX 捐赠 30,000 欧元
With a fundraising campaign among its employees, BIOMEX has collected monies to support Ukraine and is donating 30,000 euros to the German-Ukrainian Society Rhine-Neckar e. V.
BIOMEX 向海德堡霍普儿童癌症中心捐赠 10 万欧元
With 100,000 Euro, BIOMEX supports the Heidelberg Hopp Children’s Cancer Center KiTZ in the acquisition of a mass spectrometer for cancer analysis and therapy in children.
BIOMEX 开发出独特的 SARS-CoV-2 免疫血清转换板
To support the IvD and life sciences industries in their efforts against the COVID-19 pandemic, BIOMEX is developing new and unique SARS-CoV-2 immunity seroconversion panels.
提供 SARS-CoV-2 样本
In recent weeks, BIOMEX has collected more than 900 sequential bleeds from over 150 recovered COVID-19 patients to enable the progress of clinical validation of the test systems.
开发 SARS-CoV-2 抗体测试： BIOMEX 开始采集血清
To support research in developing SARS-CoV-2 antibody tests and establishing a cut-off value, BIOMEX collects serum from COVID-19 positive patients after quarantine.
